Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma

Abstract

This study suggests that chemoembolization of hepatic metastases in colorectal cancer should be further evaluated; it may be beneficial in patients who have failed systemic chemotherapy, have a good performance status, and have metastatic disease confined to the liver.